Who We Are

For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. Now we seek to make an even greater impact by applying the same science-driven, patient-forward approach that propelled our last 25 years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Through our unparalleled in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The end goal has always been better lives and now we can reach more.

And the more people we reach, the more our impact can grow. We transform lives through genetic discovery.

Our Culture

Our desire to make a positive impact on our patients extends to our employees and BioMarin is committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. We seek to provide an open, flexible, and friendly work environment to empower people and to provide them with the ability to develop their long-term careers. Ultimately, we want to be an organization where people enjoy coming to work and take pride in our efforts to help patients.

BioMarin’s Commercial organization supports our global sales and marketing efforts around the world. Our global sales force continues to solidify the company’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific. Come join our team and make a meaningful impact on patients’ lives.

FMM (Field Medical Manager)

BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target diseases that lack effective therapies and affect small numbers of patients, many of whom are children. These conditions are often inherited, difficult to diagnose, progressively debilitating and have few, if any, treatment options. BioMarin will continue to focus on advancing therapies that are the first or best of their kind.

FMM is the external-facing scientific expert on the company product(s) and therapeutic area(s) with the core responsibility of scientific engagement. This consists of the establishment and maintenance of ethical and highly scientific peer to peer relationships with leading HCPs at major academic institutions and clinics based on high-quality response to medical inquiries and proactive engagement with leading HCPs through meaningful scientific exchange conducive to improved clinical management of patients

Roles and responsibilities are the following:

1) Scientific engagement

• Scientific engagement with KOLs in healthcare, academia, payer (as required), and government organizations (as required) to disseminate scientific information, gather insights and evaluate the expert opinion of KOLs. Thus, becoming a trusted scientific partner by enhancing the understanding of the scientific and medical value of BMRN products (pre- and post/at-launch)
• Proactive KOL mapping and planning according to the scientific strategic needs of the product or therapeutic area (pre- and post/at-launch)
• Development and implementation of Scientific Exchange meetings at hospital Support the Area/Country Director on the development and implementation of regional or national Scientific Educational Programs in line with BMRN’s scientific needs, including the scientific briefing of the speakers (pre- and post/at-launch )
• Conduct drug administration (infusion) readiness training upon request (post/at-launch)
• Support institution site readiness and perform on site drug risk-management drug education/information of post-marketing studies as required (post/at-launch).
• Scientific conference support (pre- and post/at-launch)
  • pre-conference
    • Collaborate with colleagues to identify attending HCPs and arrange meetings with regional/global colleagues as necessary and/or scientific exchange

• During the conference
  • Attending relevant scientific
  • Engage in scientific exchange (ad-hoc, mostly pre-planned)
  • Staff BMRN medical booths
• post conference
  • Develop and deliver a full meeting report to be shared cross-functionally
  • Prepare post-conference updates to not-attending HCPs
• Coordinate with Medical Information the provision of answers for on- or off- label queries (pre- and post/at-launch)
• Reactive provision of information to local PAGs in lieu of Area/Country Director in collaboration with Patient Advocacy (pre- and post/at-launch)

2) Support evidence generation

• Work with investigators in company sponsored studies supporting Clin Ops and/or Study Management resources by identifying potential study sites based on their scientific capabilities, administrative readiness, and stakeholder interests, proactively informing HCPs about sponsored trials to help recruit investigators, partnering with clinical operations and CROs to ensure surveillance and compliance with study programs, and proactively engaging with investigators both during startup and ongoing throughout the study to maintain interest in and education about the study (pre- and post/at-launch)
• Work with potential investigators supporting the development and submission of IIR proposals aligned with BMRN’s strategy (mostly post/at-launch)
• Reactive support to HCPs for assistance in providing scientific information for the development of audits or pathway redesign to improve healthcare quality and effectiveness initiatives (mostly post/at-launch)
• Identify further scientific research opportunities in the area that help increase disease awareness, sharing of best practices, and identification of medical gaps (mostly post/at- launch)

3) Insight management

• Share insights and knowledge from HCPs interactions with cross-functional team members: FMMs may proactively ask questions to understand the HCP’s scientific point of view on topics to share as insights for BMRN per Data protection laws (pre- and post/at-launch)
• Identify unmet medical needs and bring back the corresponding insights to the organization so they can be actioned accordingly by the relevant party (pre- and post-launch)
• Collect data and insights to understand patient and treatment journey (pre- and post- launch)

4) Internal partnerships

• May train other internal employees on any disease state or company

• The FMM is an integral part of the BMRN team, proactively coordinating activities with other field-based personnel (sales, CRAs, access managers) and sharing insights.

Qualifications and other requirements

• Have an advanced scientific training at Bachelor of Sciences level at minimum coupled with significant medical/clinical/academic credentials typically often consisting of, but not limited to, a doctorate degree (MD, PharmD,) in the life sciences. (Preferably MD)
• Have strong external customer focus with excellent networking capabilities and ability to integrate in a multifaceted team.
• Have thorough knowledge of the local healthcare system, disease management and medical research, including methodology of clinical trials and literature search are vital. (Clinical Research Experience is a plus)
• As the business language will be in English, she/he has to have a good written and oral communication skills in English language.
• Willing to travel (min 60% of his/her time)

FMM/MSL Core Competences:

• Communication and Collaboration
• leadership
• Strategic Thinking and Planning
• Problem Solving and Decision Making
• Adaptability and Flexibility

FMM/MSL Technical Competences:

• Scientific Strategy
• Medical Engagement
• Insight Generation
• Internal and Cross-functional Partnerships
• Knowledge, Evidence Generation and Other Responsibilities.

We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.